NEW YORK (GenomeWeb News) – The National Institutes of Health will pump $62 million into more than twenty studies focused on using epigenomics to understand how environmental factors, aging, diet, and stress influence human disease.

Funded over five years under the NIH Roadmap for Medical Research's Epigenomics Program, scientists will use these funds to study the epigenome in a wide range of diseases and conditions, including tumor development, autism, hardening of the arteries, glaucoma, aging, asthma, and abnormal growth and development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.